On 25th February, ASPIRE convened the 2nd edition of the Lung Cancer Care Continuum Policy Forum Series: An Evidence Review on Local Scientific & Clinical Effort in Hong Kong. This event continues the collaborative series of roundtables dedicated to advancing lung cancer care in the APAC region.
The event brought together top lung cancer experts from various specialities, including participants from the inaugural edition in September 2024 and new voices contributing fresh perspectives. At the meeting, top lung cancer experts shared advancements in the use of AI-assisted lung cancer screening as well as blood-based biomarkers. Additionally, opportunities to enhance access, equity and quality of care across the lung cancer patient journey were also discussed.
The next edition is already in planning, as we work towards a roundtable session focused on access to treatment, funding and financing, and the patient experience.
We would like to express our gratitude to our co-hosts, Assoc. Prof. Herbert Loong, MBBS FRCP FASCO, Asia Pacific Coalition against Lung Cancer and Prof. Martin Chi-Sang Wong, The Chinese University of Hong Kong, and all our participants, Dr. Alan Sihoe, Mr. Chapman Lee, Dr. Claire Chenwen ZHONG, Prof. Kun Deng, Assist Prof. Wai Kei Jacky Lam, Prof. James Ho, Dr. Jason Junjie HUANG, Dr. Johnny KS Lau, Dr Joseph Siu Kie Au, Assist. Prof. Molly Li, Prof. Rina Hui and Assoc. Prof. Yin Ting Cheung, for their contributions which made this event a success. Your engagement and expertise are vital to driving progress.
Follow us on LinkedIn for more updates from this engagement and feel free to reach out to us if you’d like to get involved or find out more.
We would like to extend our sincere thanks to our industry partners, MSD and Roche Diagnostics, for their support and contribution for making this roundtable possible.
We are a collaborative multilateral effort focused on improving lung cancer outcomes in the Asia-Pacific region through policy reforms.
